Hiregange Disha-Gajanan, Samiya Sarit, Mizgalska Danuta, Ben-Zeev Efrat, Waghalter Miriam, Rivalta Andre, Rajan K Shanmugha, Halfon Yehuda, Breiner-Goldstein Elinor, Kaczmarczyk Igor, Sroka Aneta, Taoka Masato, Nobe Yuko, Isobe Toshiaki, Paukner Susanne, Zimmerman Ella, Bashan Anat, Potempa Jan, Yonath Ada
Department of Chemical and Structural Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Department of Microbiology, Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University, Krakow 30-387, Poland.
Nucleic Acids Res. 2025 May 22;53(10). doi: 10.1093/nar/gkaf458.
Porphyromonas gingivalis, an anaerobic pathogen in chronic periodontitis, belongs to the Bacteroidota phylum and is associated with various virulence factors. Its antibiotic-resistant strains and its propensity to form biofilms pose a challenge to effective treatment. To explore therapeutic avenues, we studied the high-resolution cryogenic electron microscope structures of ribosomes from the wild-type P. gingivalis W83 and the macrolide-resistant mutant strain ermΔporN. The structural analysis revealed unique features primarily at the ribosome periphery. Together with the distinctive distribution of ribosomal RNA modifications, these findings offer insights into the therapeutical potential, such as creation of novel therapeutic compounds inhibiting the specific cellular functions of the P. gingivalis ribosomes. Moreover, the high-resolution structure of the ermΔporN ribosome in its complex with the approved antibiotic lefamulin suggests its repurposing against P. gingivalis. Furthermore, we provide a foundation for additional effective strategies to treat periodontitis and associated systemic diseases.
牙龈卟啉单胞菌是慢性牙周炎中的一种厌氧病原体,属于拟杆菌门,与多种毒力因子相关。其耐药菌株及其形成生物膜的倾向对有效治疗构成挑战。为了探索治疗途径,我们研究了野生型牙龈卟啉单胞菌W83和大环内酯耐药突变株ermΔporN核糖体的高分辨率低温电子显微镜结构。结构分析主要在核糖体周边揭示了独特特征。结合核糖体RNA修饰的独特分布,这些发现为治疗潜力提供了见解,例如创造抑制牙龈卟啉单胞菌核糖体特定细胞功能的新型治疗化合物。此外,ermΔporN核糖体与已批准的抗生素左法莫林复合物的高分辨率结构表明其可重新用于对抗牙龈卟啉单胞菌。此外,我们为治疗牙周炎及相关全身性疾病的其他有效策略奠定了基础。